Idiopathic Anemia of Aging (IAA)
NCT00104169 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2008-08-29
Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
Conditions
- Anemia
- Aging
Interventions
- DRUG
-
Epoetin Alfa
Sponsors & Collaborators
-
National Institute on Aging (NIA)
lead NIH
Principal Investigators
-
William Ershler, MD · NIA, NIH
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2007-05-31
- Completion
- 2007-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
NCT00210977 ·Status: WITHDRAWN
-
Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
NCT00399269 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Chronic Anemia With Epoetin Alfa in Elderly
NCT00337441 ·Status: UNKNOWN ·Phase: PHASE2
-
Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
NCT00434330 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
NCT01628107 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
NCT02064426 ·Status: COMPLETED ·Phase: PHASE2
-
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
NCT00058331 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
NCT00495365 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
NCT00211029 ·Status: COMPLETED
-
Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
NCT00146224 ·Status: COMPLETED ·Phase: PHASE3
-
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
NCT03485053 ·Status: TERMINATED ·Phase: PHASE2
-
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
NCT00400686 ·Status: COMPLETED ·Phase: NA
-
A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
NCT03350347 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Response to Iron and Erythropoietin Stimulating Agents
NCT03658876 ·Status: COMPLETED ·Phase: PHASE4
-
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
NCT05699109 ·Status: COMPLETED
-
The Clinical Evaluation of the Dose of Erythropoietins Trial
NCT00827021 ·Status: COMPLETED ·Phase: PHASE3
-
The Benefits of a Preoperative Anemia Management Program
NCT01888003 ·Status: TERMINATED ·Phase: NA
-
Comparison Among Erythropoietin Stimulating Agents
NCT02049346 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation
NCT01290328 ·Status: TERMINATED ·Phase: NA
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
NCT00233597 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
NCT00563355 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
NCT00228995 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.
NCT00364455 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 ·Status: WITHDRAWN ·Phase: PHASE2